PT1083902E - Novas formulacoes galenicas de meloxicam para a administracao oral - Google Patents

Novas formulacoes galenicas de meloxicam para a administracao oral

Info

Publication number
PT1083902E
PT1083902E PT99915690T PT99915690T PT1083902E PT 1083902 E PT1083902 E PT 1083902E PT 99915690 T PT99915690 T PT 99915690T PT 99915690 T PT99915690 T PT 99915690T PT 1083902 E PT1083902 E PT 1083902E
Authority
PT
Portugal
Prior art keywords
meloxicam
oral administration
galenic formulations
new galenic
new
Prior art date
Application number
PT99915690T
Other languages
English (en)
Inventor
Dietrich Turck
Thomas Bock
Paul Sagmuller
Peter Sieger
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT1083902E publication Critical patent/PT1083902E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT99915690T 1998-03-27 1999-03-23 Novas formulacoes galenicas de meloxicam para a administracao oral PT1083902E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98105569A EP0945134A1 (de) 1998-03-27 1998-03-27 Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
PCT/EP1999/001949 WO1999049867A1 (de) 1998-03-27 1999-03-23 Neue galenische zubereitungsformen von meloxicam zur oralen applikation

Publications (1)

Publication Number Publication Date
PT1083902E true PT1083902E (pt) 2004-04-30

Family

ID=8231652

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99915690T PT1083902E (pt) 1998-03-27 1999-03-23 Novas formulacoes galenicas de meloxicam para a administracao oral

Country Status (25)

Country Link
US (1) US6869948B1 (pt)
EP (2) EP0945134A1 (pt)
JP (1) JP3639532B2 (pt)
KR (1) KR100589299B1 (pt)
CN (1) CN1163231C (pt)
AR (1) AR016197A1 (pt)
AT (1) ATE254920T1 (pt)
AU (1) AU762322C (pt)
BR (1) BR9909192A (pt)
CA (1) CA2326517C (pt)
DE (1) DE59907871D1 (pt)
DK (1) DK1083902T3 (pt)
ES (1) ES2212547T3 (pt)
HK (1) HK1034183A1 (pt)
HU (1) HUP0101246A3 (pt)
IL (2) IL137652A0 (pt)
NO (1) NO326852B1 (pt)
NZ (1) NZ507382A (pt)
PL (1) PL192967B1 (pt)
PT (1) PT1083902E (pt)
TR (1) TR200002786T2 (pt)
TW (1) TWI236914B (pt)
UY (1) UY25441A1 (pt)
WO (1) WO1999049867A1 (pt)
ZA (1) ZA200004178B (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2257886T3 (es) 1998-12-01 2006-08-01 Dr. Reddy's Research Foundation Nueva composicion farmaceutica y el proceso para su preparacion.
AU1548001A (en) 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
EP1303273A1 (en) 2000-05-26 2003-04-23 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
WO2001091751A1 (en) * 2000-05-30 2001-12-06 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US7120656B1 (en) 2000-10-04 2006-10-10 Marvell International Ltd. Movable tap finite impulse response filter
WO2002067894A2 (en) * 2001-02-27 2002-09-06 Ranbaxy Laboratories Limited Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
EP1250921A1 (en) * 2001-04-21 2002-10-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Fast disintegrating meloxicam tablet
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1348436A1 (en) * 2002-03-30 2003-10-01 Boehringer Ingelheim International GmbH Meloxicam suppositories
GB0209257D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
EP1685829B1 (de) 2002-11-22 2008-04-09 Grünenthal GmbH Verwendung von (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexan-1,3-diol zur Behandlung von Entzündungsschmerz
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
JP5546715B2 (ja) * 2003-03-17 2014-07-09 日本たばこ産業株式会社 Cetp阻害剤の医薬組成物
KR100620239B1 (ko) * 2004-01-05 2006-09-13 신일제약주식회사 용해도 및 안정성이 향상된 경구투여용 멜록시캄 고형제조성물
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
US20060025408A1 (en) * 2004-08-02 2006-02-02 Sundaram Venkataraman Process for the preparation of crystalline form-1 of 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
WO2006042034A2 (en) 2004-10-08 2006-04-20 Abbott Laboratories Salt and crystalline forms thereof of a drug
HU227359B1 (en) * 2004-12-18 2011-04-28 Egis Gyogyszergyar Nyilvanosan Mikodi Ruszvunytarsasag Process for producing meloxicam and meloxicam potassium salt of high purity
EP1824493B1 (en) 2004-12-06 2008-08-13 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam
AU2006214166B2 (en) 2005-02-17 2011-09-29 Zoetis Belgium S.A. Transmucosal administration of drug compositions for treating and preventing disorders in animals
CA2614468A1 (en) * 2005-07-15 2007-01-25 Teva Pharmaceutical Industries Ltd. Novel granulation process and granulate produced therefrom
EP1942902A1 (en) * 2005-09-30 2008-07-16 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
US7572641B2 (en) 2005-11-22 2009-08-11 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions comprising meloxicam and methods of their preparation
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
US20070281927A1 (en) * 2006-06-06 2007-12-06 Shanthakumar Tyavanagimatt Anti-inflammatory and analgesic compositions and related methods
US8124603B2 (en) * 2008-01-22 2012-02-28 Thar Pharmaceuticals In vivo studies of crystalline forms of meloxicam
TR200809200A1 (tr) 2008-12-01 2009-12-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Meloksikam içeren farmasötik formülasyonlar
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
BR112012022073A2 (pt) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US8791105B2 (en) 2010-07-14 2014-07-29 Kansas State University Research Foundation Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration
US20170281640A1 (en) * 2016-04-04 2017-10-05 Productos Maver, S.A. De C.V. Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)
US20220002283A1 (en) * 2018-11-05 2022-01-06 Mylan Laboratories Limited Meloxicam co-crystals
WO2020219406A1 (en) 2019-04-22 2020-10-29 Mylan Specialty L.P. Meloxicam co-crystal compositions
CN116437902A (zh) 2020-11-06 2023-07-14 迈兰实验室有限公司 包含美洛昔康的医药组成物
CN112587497A (zh) * 2020-12-25 2021-04-02 苏州中化药品工业有限公司 一种美洛昔康混悬液胶囊剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
IT1207994B (it) 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
JP2000500449A (ja) * 1995-11-13 2000-01-18 ピットミー・インターナショナル・ナムローゼ・フェンノートシャップ 一酸化二窒素を含む鎮痛剤、抗炎症剤、および抗発熱剤のための投与媒体とそれらの医薬組成物
AU750125B2 (en) * 1997-08-27 2002-07-11 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability

Also Published As

Publication number Publication date
EP1083902B1 (de) 2003-11-26
CA2326517A1 (en) 1999-10-07
HK1034183A1 (en) 2001-10-19
UY25441A1 (es) 1999-11-17
KR20010034698A (ko) 2001-04-25
BR9909192A (pt) 2000-12-05
JP2002509886A (ja) 2002-04-02
CN1163231C (zh) 2004-08-25
PL342988A1 (en) 2001-07-16
IL137652A0 (en) 2001-10-31
EP0945134A1 (de) 1999-09-29
WO1999049867A1 (de) 1999-10-07
ATE254920T1 (de) 2003-12-15
AU762322B2 (en) 2003-06-26
NO20004823L (no) 2000-11-22
TR200002786T2 (tr) 2001-01-22
AU762322C (en) 2004-02-12
DK1083902T3 (da) 2004-03-29
AU3417199A (en) 1999-10-18
NZ507382A (en) 2003-08-29
HUP0101246A2 (hu) 2002-05-29
EP1083902A1 (de) 2001-03-21
HUP0101246A3 (en) 2002-08-28
US6869948B1 (en) 2005-03-22
NO326852B1 (no) 2009-03-02
DE59907871D1 (de) 2004-01-08
NO20004823D0 (no) 2000-09-26
PL192967B1 (pl) 2006-12-29
IL137652A (en) 2006-10-05
AR016197A1 (es) 2001-06-20
ES2212547T3 (es) 2004-07-16
KR100589299B1 (ko) 2006-06-14
TWI236914B (en) 2005-08-01
ZA200004178B (en) 2002-04-24
JP3639532B2 (ja) 2005-04-20
CN1295478A (zh) 2001-05-16
CA2326517C (en) 2008-06-10

Similar Documents

Publication Publication Date Title
PT1083902E (pt) Novas formulacoes galenicas de meloxicam para a administracao oral
PT1110543E (pt) Composicao de libertacao prolongada para administracao oral
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
EE04901B1 (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
PL356358A1 (en) Solid dosage form of someticone for oral administration
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
EE200200075A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kompositsioonid
PT868911E (pt) Formulacoes de rapamicina para administracao oral
PT1136081E (pt) Composicoes de libertacao controlada para a administracao parenterica de microlidos
PT835103E (pt) Nanoparticulas para administracao oral de agentes farmaceuticos de baixa solubilidade
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO996044L (no) Rapamycinformuleringer for oral administrasjon
EP1294368A4 (en) TREATMENT OF ORAL ADMINISTRATION OF DIMETHYL SULFONE
HUP0201667A2 (en) Oral form of administration
EE04095B1 (et) Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks
NO20003799D0 (no) Innkorporering av kolesterol-senkende midler i konfektdosisformer
PT1117420E (pt) Composicoes farmaceuticas baseadas em alfa-ciclodextrina para administracao oral de analogos de lh-rh
NO20032581D0 (no) Farmasöytisk formulering av gepiron for oral administrering
ITMI992736A0 (it) Composizioni farmaceutiche per la somministrazione localizzata nel cav o orale di farmaci antiinfiammatori non stereoidei utili per la terapi
NO20003284L (no) Farmasøytisk preparat for oral administrering
PT946184E (pt) Novas formulacoes para a administracao de fluoxetina
PT1137398E (pt) Preparacao farmaceutica para inalacao de um opiaceo